The Official Website of the Long-Term Investor
Results 1 - 10 of 30 : 1 2 3 Next
Why Shire May Be About to Take Off
Don't just ask, "How much inventory?" Ask, "What kind?"
Shire Beats on Revenue, Matches Expectations on EPS
Just the facts, Fool.
Why Shire May Be About to Take Off
Don't just ask, "How much inventory?" Ask, "What kind?"
One Reason the Street Should Expect Big Things From Salix Pharmaceuticals
Don't just ask, "How much inventory?" Ask, "What kind?"
The 20 Fastest Growers in Pharma
Yesterday's proven track records may reveal tomorrow's winners.
Another drug approved.
One Reason the Street Should Expect Big Things From Watson Pharmaceuticals
Don't just ask, "How much inventory?" Ask, "What kind?"
The ADHD medicine maker is busy making big moves.
Rare Diseases, Big Opportunity
"Orphan" drugs to keep your eye on.
Minor Delay, Major Missed Opportunity
Protalix and Pfizer's drug gets delayed.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK